The Role of JAK Inhibitors in the Management of Atopic Dermatitis

This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD. o  The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist o  Introduction of faculty, affiliations, and disclosures We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast. Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose. o  Accreditation and support statement PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by educational grants from Incyte. Learn more about your ad choices. Visit megaphone.fm/adchoices